Oak Hill Wealth Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$2.21M Sell
2,901
-8
-0.3% -$5.95K 0.41% 40
2025
Q2
$2.26M Buy
2,909
+15
+0.5% +$11.7K 0.47% 33
2025
Q1
$2.39M Sell
2,894
-56
-2% -$46.6K 0.55% 32
2024
Q4
$2.28M Buy
+2,950
New +$2.44M 0.54% 32
2024
Q3
Sell
-2,576
Closed -$2.32M 175
2024
Q2
$2.33M Buy
+2,576
New +$2.06M 0.71% 23
2024
Q1
Sell
-2,634
Closed -$1.87M 161
2023
Q4
$1.54M Sell
2,634
-42
-2% -$24.5K 0.53% 26
2023
Q3
$1.44M Sell
2,676
-323
-11% -$166K 0.55% 26
2023
Q2
$1.39M Sell
2,999
-9
-0.3% -$3.77K 0.51% 27
2023
Q1
$1.04M Sell
3,008
-20
-0.7% -$6.75K 0.41% 34
2022
Q4
$1.11M Buy
+3,028
New +$1.07M 0.46% 32

Other funds holding LLY

Oak Hill Wealth Advisors's LLY Position: Q3 2025 in Review

Oak Hill Wealth Advisors reduced its Eli Lilly (LLY) stake by 0.28% in Q3 2025, selling an estimated $5.95K and leaving 2,901 shares worth $2.21M. The position accounts for 0.41% of the portfolio, ranked #40.

Oak Hill Wealth Advisors first reported a position in LLY in Q4 2022 and has held it in 10 quarters since. The position peaked at $2.39M in Q1 2025. 3,897 funds tracked by Wall St. Rank hold LLY as of Q3 2025.

  • Oak Hill Wealth Advisors held 2,901 shares of Eli Lilly worth $2.21M as of Q3 2025.
  • Oak Hill Wealth Advisors sold 8 Eli Lilly shares in Q3 2025, an estimated $5.95K.
  • Eli Lilly made up 0.41% of Oak Hill Wealth Advisors's portfolio in Q3 2025, its #40 holding.
  • Oak Hill Wealth Advisors first reported a position in Eli Lilly in Q4 2022 and has held it in 10 quarters since.
  • Oak Hill Wealth Advisors's Eli Lilly position peaked at $2.39M in Q1 2025.
  • 3,897 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2025.

Based on Oak Hill Wealth Advisors's 13F filing for Q3 2025, filed 30 Oct 2025.